C4d deposits in renal allografts are associated with inferior graft outcome.
Böhmig
G A
GA
Department of Internal Medicine III, the Department of Laboratory Medicine, the Institute of Clinical Pathology, and the Institute of Immunology, University of Vienna, Vienna, Austria.
Exner
M
M
Watschinger
B
B
Wenter
C
C
Wahrmann
M
M
Osterreicher
C
C
Säemann
M D
MD
Mersich
N
N
Hörl
W H
WH
Zlabinger
G J
GJ
Regele
H
H
D000208:Acute Disease; D015415:Biomarkers / Q000032:analysis; D001706:Biopsy; D003181:Complement C4 / Q000032:analysis*; D015935:Complement C4b; D003404:Creatinine / Q000097:blood; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D007668:Kidney / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D010446:Peptide Fragments / Q000032:analysis*; D012189:Retrospective Studies; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D015415:Biomarkers; D003181:Complement C4; D010446:Peptide Fragments; D015935:Complement C4b; C032261:complement C4d; D003404:Creatinine